61 related articles for article (PubMed ID: 38506084)
21. Steroid receptor coactivator-1 interacts with NF-κB to increase VEGFC levels in human thyroid cancer.
Gao B; Guo L; Luo D; Jiang Y; Zhao J; Mao C; Xu Y
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29717026
[TBL] [Abstract][Full Text] [Related]
22. Anti-metastatic potential of a proton beam is regulated by p38 MAPK/c-Fos signaling pathway in TPA-treated HepG2 human hepatocellular carcinoma.
Chun SY; Kim S; Nam KS; Lee KS
Biomed Pharmacother; 2018 Mar; 99():904-912. PubMed ID: 29710490
[TBL] [Abstract][Full Text] [Related]
23. Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling.
Tong Z; Li M; Wang W; Mo P; Yu L; Liu K; Ren W; Li W; Zhang H; Xu J; Yu C
J Biol Chem; 2015 Jul; 290(30):18596-608. PubMed ID: 26082485
[TBL] [Abstract][Full Text] [Related]
24. NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis.
Qin L; Wu YL; Toneff MJ; Li D; Liao L; Gao X; Bane FT; Tien JC; Xu Y; Feng Z; Yang Z; Xu Y; Theissen SM; Li Y; Young L; Xu J
Cancer Res; 2014 Jul; 74(13):3477-88. PubMed ID: 24769444
[TBL] [Abstract][Full Text] [Related]
25. SRC-1 and Twist1 expression positively correlates with a poor prognosis in human breast cancer.
Xu Y; Hu B; Qin L; Zhao L; Wang Q; Wang Q; Xu Y; Jiang J
Int J Biol Sci; 2014; 10(4):396-403. PubMed ID: 24719557
[TBL] [Abstract][Full Text] [Related]
26. Sorafenib inhibits TPA-induced MMP-9 and VEGF expression via suppression of ERK/NF-κB pathway in hepatocellular carcinoma cells.
Chiang IT; Liu YC; Wang WH; Hsu FT; Chen HW; Lin WJ; Chang WY; Hwang JJ
In Vivo; 2012; 26(4):671-81. PubMed ID: 22773582
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness.
Liu Y; Tong Z; Li T; Chen Q; Zhuo L; Li W; Wu RC; Yu C
Hepatology; 2012 Sep; 56(3):1015-24. PubMed ID: 22473901
[TBL] [Abstract][Full Text] [Related]
28. Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1.
McBryan J; Theissen SM; Byrne C; Hughes E; Cocchiglia S; Sande S; O'Hara J; Tibbitts P; Hill AD; Young LS
Cancer Res; 2012 Jan; 72(2):548-59. PubMed ID: 22108824
[TBL] [Abstract][Full Text] [Related]
29. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.
Qin L; Chen X; Wu Y; Feng Z; He T; Wang L; Liao L; Xu J
Cancer Res; 2011 Mar; 71(5):1742-51. PubMed ID: 21343398
[TBL] [Abstract][Full Text] [Related]
30. Estrogen-dependent and estrogen-independent mechanisms contribute to AIB1-mediated tumor formation.
Torres-Arzayus MI; Zhao J; Bronson R; Brown M
Cancer Res; 2010 May; 70(10):4102-11. PubMed ID: 20442283
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness.
Xu Y; Chen Q; Li W; Su X; Chen T; Liu Y; Zhao Y; Yu C
Oncogene; 2010 Jun; 29(23):3386-97. PubMed ID: 20305690
[TBL] [Abstract][Full Text] [Related]
32. The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis.
Qin L; Liu Z; Chen H; Xu J
Cancer Res; 2009 May; 69(9):3819-27. PubMed ID: 19383905
[TBL] [Abstract][Full Text] [Related]
33. Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation.
Wang S; Yuan Y; Liao L; Kuang SQ; Tien JC; O'Malley BW; Xu J
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):151-6. PubMed ID: 19109434
[TBL] [Abstract][Full Text] [Related]
34. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression.
Qin L; Liao L; Redmond A; Young L; Yuan Y; Chen H; O'Malley BW; Xu J
Mol Cell Biol; 2008 Oct; 28(19):5937-50. PubMed ID: 18644862
[TBL] [Abstract][Full Text] [Related]
35. Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression.
Yan J; Erdem H; Li R; Cai Y; Ayala G; Ittmann M; Yu-Lee LY; Tsai SY; Tsai MJ
Cancer Res; 2008 Jul; 68(13):5460-8. PubMed ID: 18593949
[TBL] [Abstract][Full Text] [Related]
36. Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer.
Al-azawi D; Ilroy MM; Kelly G; Redmond AM; Bane FT; Cocchiglia S; Hill AD; Young LS
Oncogene; 2008 May; 27(21):3021-31. PubMed ID: 18059336
[TBL] [Abstract][Full Text] [Related]
37. Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice.
Chung AC; Zhou S; Liao L; Tien JC; Greenberg NM; Xu J
Cancer Res; 2007 Jun; 67(12):5965-75. PubMed ID: 17575167
[TBL] [Abstract][Full Text] [Related]
38. Regulation of matrix metalloproteinase gene expression.
Yan C; Boyd DD
J Cell Physiol; 2007 Apr; 211(1):19-26. PubMed ID: 17167774
[TBL] [Abstract][Full Text] [Related]
39. Introduction to NF-kappaB: players, pathways, perspectives.
Gilmore TD
Oncogene; 2006 Oct; 25(51):6680-4. PubMed ID: 17072321
[TBL] [Abstract][Full Text] [Related]
40. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.
Agoulnik IU; Vaid A; Bingman WE; Erdeme H; Frolov A; Smith CL; Ayala G; Ittmann MM; Weigel NL
Cancer Res; 2005 Sep; 65(17):7959-67. PubMed ID: 16140968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
